Results 191 to 200 of about 2,624,990 (309)

Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 years [PDF]

, 2007
Mikko Laaksonen, Kirsi Talala, Tuija Martelin, Ossi Rahkonen, Eva Roos, Satu Helakorpi, Tiina Laatikainen, Ritva Prättälä   +7 more
openalex   +1 more source

PR Interval and the Risks of Recurrent Syncope and All-Cause Mortality in Patients Presenting With Syncope. [PDF]

J Am Heart Assoc
Knudsen A, Struijk JJ, Riahi S, Andersen MP, Christensen HC, Torp-Pedersen C, Kragholm K, Polcwiartek C, Kanters JK, Graff C.   +9 more
europepmc   +1 more source

Effect of Implementing a Dashboard With or Without a Best Practice Alert on HLA‐B*58:01 Testing Rates Among Allopurinol Users at VA Medical Centers

Arthritis Care &Research, EarlyView.
Objective The American College of Rheumatology recommends HLA‐B*58:01 allele testing before the initiation of allopurinol, specifically among Asian and African American/Black patients, due to their increased risk for severe hypersensitivity reactions. However, testing rates remain low at many health care facilities.
Abimbola Fadairo‐Azinge, Gabriela Schmajuk, Sristi Sharma, Colleen P. Flanagan, Sara Faghihi‐Kashani, Ning Zhang, Mary A. Whooley   +6 more
wiley   +1 more source

Cardiovascular disease and all-cause mortality : influence of fitness, fatness and genetic factors

, 2017
Gabriel Högström
openalex   +1 more source

Association Between Basal Metabolic Rate and All-Cause Mortality in a Prospective Cohort of Southern Chinese Adults

, 2022
Fengyu Han, Feng Hu, Tao Wang, Wei Zhou, Linjuan Zhu, Xiao Huang, Huihui Bao, Xiaoshu Cheng   +7 more
openalex   +1 more source

Non-albumin proteinuria is associated with all-cause mortality in community-dwelling adults. [PDF]

Sci Rep
Kabasawa K, Hosojima M, Ito Y, Kabasawa H, Tanaka J, Iino N, Tsugane S, Nakamura K, Saito A, Yamamoto S.   +9 more
europepmc   +1 more source

Prevalence of Systemic Lupus Erythematosus in Australia, 2010–2022: A Population‐Based Study Using Linked National Administrative Health Data

Arthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed ...
Lucinda Roper, Rachel Black, Joanna Tieu, Winnie Chen, Matthew Parker, Catherine Hill, Natasha Nassar, Mandana Nikpour   +7 more
wiley   +1 more source

Chronic kidney disease: an independent risk factor of all-cause mortality for elderly Chinese patients with chronic heart failure

, 2013
Shihui Fu, Bing Zhu, Yu‐Xiao Zhang, Shuangyan Yi, Yuan Liu, Tiehui Xiao, Liang Wang, B. Yongyi, Caiyi Lu, Ping Ye, Leiming Luo   +10 more
openalex   +2 more sources

The PARIS score can reliably predict 7-day all-cause mortality for both acute medical and surgical patients: an international validation study [PDF]

, 2018
Mikkel Brabrand, Torben Knudsen, Jesper Hallas, Colin A. Graham, John Kellett   +4 more
openalex   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source